FUKOKU MUTUAL LIFE INSURANCE Co Cuts Stake in Intuitive Surgical, Inc. $ISRG

FUKOKU MUTUAL LIFE INSURANCE Co cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,086 shares of the medical equipment provider’s stock after selling 140 shares during the period. FUKOKU MUTUAL LIFE INSURANCE Co’s holdings in Intuitive Surgical were worth $1,134,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Brighton Jones LLC increased its holdings in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after buying an additional 731 shares during the last quarter. PFG Advisors grew its position in Intuitive Surgical by 31.4% during the first quarter. PFG Advisors now owns 7,670 shares of the medical equipment provider’s stock valued at $3,799,000 after acquiring an additional 1,833 shares during the period. Proficio Capital Partners LLC grew its position in Intuitive Surgical by 2.9% during the first quarter. Proficio Capital Partners LLC now owns 1,872 shares of the medical equipment provider’s stock valued at $927,000 after acquiring an additional 52 shares during the period. Oak Thistle LLC acquired a new stake in Intuitive Surgical during the first quarter worth about $2,359,000. Finally, SYM FINANCIAL Corp purchased a new position in shares of Intuitive Surgical in the 1st quarter worth about $1,120,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ISRG. Hsbc Global Res upgraded Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Evercore ISI boosted their price objective on shares of Intuitive Surgical from $450.00 to $540.00 in a research note on Wednesday, October 22nd. Robert W. Baird set a $655.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Finally, Rothschild & Co Redburn lifted their target price on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Insider Buying and Selling

In other news, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. This trade represents a 9.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Brian Edward Miller sold 3,500 shares of the business’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $575.00, for a total value of $2,012,500.00. Following the completion of the transaction, the executive vice president owned 5,758 shares in the company, valued at approximately $3,310,850. This trade represents a 37.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 116,164 shares of company stock worth $61,916,172 over the last quarter. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Up 3.3%

ISRG opened at $564.64 on Thursday. The firm has a market capitalization of $202.41 billion, a P/E ratio of 74.69, a P/E/G ratio of 4.94 and a beta of 1.62. The firm’s 50 day moving average is $487.92 and its 200-day moving average is $503.76. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the prior year, the firm earned $1.84 earnings per share. The business’s quarterly revenue was up 22.9% compared to the same quarter last year. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.